May 5, 2022 saw the launching ceremony of the Born with Love Gynecological Oncology Special Fund by the Shanghai Soong Ching Ling Foundation.
At the launching ceremony, Director of Shanghai First Maternity and Infant Hospital and its Chief Physician of Gynecology Prof. Wang Yu who has initiated the establishment of this special fund, introduced its purpose. Geographical differences, communication barriers and uneven economic development have prevented many gynaecological tumour patients from having access to standardised and effective treatment; due to uneven quality of medical care and limitations of local testing conditions, the level of diagnosis and treatment of gynaecological tumours across the country has not yet reached complete uniformity and standardisation; moreover, many patients are unable to receive effective treatment because of personal or family financial reasons. It is against such a background that the Shanghai Soong Ching Ling Foundation's Born with Love Gynecological Oncology Special Fund has been created, aiming to care for a wider range of gynaecological disease patients, nurture and improve the skills of gynaecologists in more primary care institutions, and encourage the participation of all relevant stakeholders in the cause.
In her speech at the launching ceremony, Ms. Zhu Yaping, Assistant Secretary General of Shanghai Soong Ching Ling Foundation, expressed her gratitude to the initiators, the experts, as well as friends and supporters from all walks of life who have cared about and contributed to the special fund, with the hope that in the future, various stakeholders will continue to join hands in promoting the charitable causes that Ms. Soong Ching Ling was passionate about.
Shanghai Soong Ching Ling Foundation's Born with Love Gynecological Oncology Special Fund will help improve the treatment level of gynecological oncology in various regions by providing financial support to impoverished patients, training doctors, raising awareness and promoting education, allowing more female patients the access to treatment.